0001193125-12-272051.txt : 20120615 0001193125-12-272051.hdr.sgml : 20120615 20120615130317 ACCESSION NUMBER: 0001193125-12-272051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120613 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20120615 DATE AS OF CHANGE: 20120615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRIDEX CORP CENTRAL INDEX KEY: 0001006045 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770210467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27598 FILM NUMBER: 12909546 BUSINESS ADDRESS: STREET 1: 1212 TERRA BELLA AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509404700 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 8-K 1 d368040d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

June 13, 2012

 

 

IRIDEX CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   0-27598   77-0210467

(State or other jurisdiction of

incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1212 Terra Bella Avenue

Mountain View, California 94043

(Address of principal executive offices, including zip code)

(650) 940-4700

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders of IRIDEX Corporation (“IRIDEX” or the “Company”) held on June 13, 2012 (the “Annual Meeting”), the stockholders of IRIDEX re-elected the following individuals to the Board of Directors. Each Director will serve for the ensuing year or until their respective successors are duly elected and qualified.

 

Nominee

   Votes For      Votes Against      Broker Non
Votes*
 

Dominik Beck, Ph.D.

     5,406,031         129,136         1,812,221   

Sanford Fitch

     5,060,716         474,451         1,812,221   

Garrett A. Garrettson, Ph.D.

     5,060,683         474,484         1,812,221   

James B. Hawkins

     5,405,931         129,236         1,812,221   

William M. Moore

     5,179,031         356,136         1,812,221   

Ruediger Naumann-Etienne, Ph.D.

     5,287,683         247,484         1,812,221   

 

* Broker non-votes do not affect the outcome of the election.

In addition, the following proposals were voted on and approved at the Annual Meeting.

 

     Votes For      Votes Against      Abstentions      Broker Non Votes  

Proposal to ratify the appointment of Burr Pilger Mayer, Inc. as the independent registered public accountants of the Company for the fiscal year ending December 29, 2012

     7,033,254         33,781         53,090         227,263   

Proposal to approve an amendment to the amended and restated 2008 Equity Incentive Plan to add 400,000 shares to the shares reserved for issuance thereunder

     4,734,048         797,569         3,550         1,812,221   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      IRIDEX CORPORATION
    By:  

/s/ DOMINIK BECK

     

Dominik Beck, Ph.D.

President and Chief Executive Officer

Date: June 15, 2012